Several analysts have recently updated their ratings and price targets for PACS Group (NYSE: PACS): 12/15/2025 – PACS Group had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 12/12/2025 – PACS Group was given a new $40.00 price target on by analysts at Truist Financial Corporation. 12/8/2025 – PACS Group had its “hold […]

FIGS (NYSE: FIGS) recently received a number of ratings updates from brokerages and research firms: 12/15/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 12/13/2025 – FIGS was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating. 12/10/2025 – FIGS was upgraded by analysts […]

Several brokerages have updated their recommendations and price targets on shares of Lumentum (NASDAQ: LITE) in the last few weeks: 12/17/2025 – Lumentum had its price target raised by analysts at Morgan Stanley from $190.00 to $304.00. They now have an “equal weight” rating on the stock. 12/15/2025 – Lumentum had its “hold (c-)” rating […]

Several analysts have recently updated their ratings and price targets for Duolingo (NASDAQ: DUOL): 12/15/2025 – Duolingo had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 12/11/2025 – Duolingo had its price target raised by analysts at Jefferies Financial Group Inc. from $210.00 to $220.00. They now have a “hold” rating on the […]

Similarweb (NYSE: SMWB) has recently received a number of price target changes and ratings updates: 12/15/2025 – Similarweb had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings. 12/15/2025 – Similarweb had its “market outperform” rating reaffirmed by analysts at Citigroup Inc.. 12/8/2025 – Similarweb had its “sell (d-)” rating reaffirmed by analysts at […]

AstraZeneca (NASDAQ: AZN) has recently received a number of price target changes and ratings updates: 12/10/2025 – AstraZeneca had its “buy” rating reaffirmed by analysts at HSBC Holdings plc. They now have a $108.00 price target on the stock. 12/9/2025 – AstraZeneca had its “buy” rating reaffirmed by analysts at Cowen Inc. 12/3/2025 – AstraZeneca […]

uniQure (NASDAQ: QURE) has recently received a number of price target changes and ratings updates: 12/11/2025 – uniQure had its price target lowered by analysts at Stifel Nicolaus from $50.00 to $40.00. They now have a “buy” rating on the stock. 12/8/2025 – uniQure had its price target lowered by analysts at Mizuho from $60.00 […]

Several brokerages have updated their recommendations and price targets on shares of Auna (NYSE: AUNA) in the last few weeks: 12/15/2025 – Auna had its “sell (d)” rating reaffirmed by analysts at Weiss Ratings. 12/13/2025 – Auna was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating. 12/8/2025 – […]